STOCK TITAN

[6-K] HUTCHMED (China) Limited American Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K
Rhea-AI Filing Summary
Riscrivi il testo seguente:
Reescribe el siguiente texto:
다음 텍스트를 다시 작성하세요:
Réécrivez le texte suivant :
Schreiben Sie den folgenden Text um:
Positive
  • None.
Negative
  • None.
Riscrivi il testo seguente:
Reescribe el siguiente texto:
다음 텍스트를 다시 작성하세요:
Réécrivez le texte suivant :
Schreiben Sie den folgenden Text um:
UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THESECURITIES EXCHANGE ACT OF 1934For the Month of July 2025Commission File Number: 001-37710
HUTCHMED (CHINA) LIMITED(Translation of registrant’s name into English)
48th Floor, Cheung Kong Center, 2 Queen’s Road Central, Hong Kong (Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.Form 20-F  ⌧             Form 40-F  


HUTCHMED (CHINA) LIMITEDForm 6-KEXHIBIT INDEX
Exhibit No.    Description
Exhibit 99.1Announcement relating to notice of announcement of 2025 interim results
2

SIGNATUREPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
HUTCHMED (CHINA) LIMITED
By:/s/ Johnny Cheng
Name:Johnny Cheng
Title:Chief Financial Officer
Date: July 3, 2025
3

FAQ

What information is available?

This document appears to contain limited substantive content.
Hutchmed (China) Limited

NASDAQ:HCM

HCM Rankings

HCM Latest News

HCM Latest SEC Filings

HCM Stock Data

2.62B
174.20M
0.13%
4.05%
0.22%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
Hong Kong
CAMBRIDGE